Enhancing vaccine safety capacity globally: a lifecycle perspective

Chen, Robert T.; Shimabukuro, Tom T.; Martin, David B.; Zuber, Patrick L.F.; Weibel, Daniel M.; Sturkenboom, Miriam

doi:10.1016/j.vaccine.2015.06.073

Back to Previous Page

Enhancing vaccine safety capacity globally: a lifecycle perspective

Published Date:

Oct 01 2015

Publisher's site:

http://dx.doi.org/10.1016/j.vaccine.2015.06.073

Source:

Vaccine. 33(0 4):D46-D54

Language:

English

[PDF-313.32 KB]

Details:

Alternative Title:

Vaccine

Personal Author:

Chen, Robert T. ; Shimabukuro, Tom T. ; Martin, David B. ; Zuber, Patrick L.F. ; Weibel, Daniel M. ; ... More ▼

Description:

Major vaccine safety controversies have arisen in several countries beginning in the last decades of 20th century. Such periodic vaccine safety controversies are unlikely to go away in the near future as more national immunization programs mature with near elimination of target vaccine-preventable diseases that result in relative greater prominence of adverse events following immunizations, both true reactions and temporally coincidental events. There are several ways in which vaccine safety capacity can be improved to potentially mitigate the impact of future vaccine safety controversies. This paper aims to take a "lifecycle" approach, examining some potential pre- and post-licensure opportunities to improve vaccine safety, in both developed (specifically U.S. and Europe) and low- and middle-income countries.

Subject:

[+]

Pubmed ID:

26433922

Pubmed Central ID:

PMC4663114

Document Type:

Journal Article

Funding:

001/World Health Organization/International ; CC999999/Intramural CDC HHS/United States ;

Place as Subject:

United States

Collection(s):

CDC Public Access

Main Document Checksum:

[+]

File Type:

Supporting Files:

	nihms732969.nxml	text/xml
	nihms732969f1.gif	image/gif
	nihms732969f1.jpg	image/jpeg

No Related Documents.

Surveillance systems and methods for monitoring the post-marketing safety of influenza vaccines at the Centers for Disease Control and Prevention

[PDF - 645.84 KB]

Personal Author:

Moro, Pedro L. ; Li, Rongxia ; ...

Published Date:

June 16 2016

Source:

Expert Opin Drug Saf. 15(9):1175-1183

Description:

Introduction:Annual influenza vaccine safety monitoring is an important component of the influenza vaccination program in the United States to ensure ...

File Type:

[PDF - 645.84 KB]

File Type:

[PDF - 645.84 KB]
The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety

[PDF - 296.10 KB]

Personal Author:

McNeil, Michael M. ; Gee, Julianne ; ...

Published Date:

August 06 2014

Source:

Vaccine. 32(42):5390-5398

Description:

The Vaccine Safety Datalink (VSD) is a collaborative project between the Centers for Disease Control and Prevention (CDC) and 9 health care organizati...

File Type:

[PDF - 296.10 KB]

File Type:

[PDF - 296.10 KB]
Cognitive testing to evaluate revisions to the Vaccine Adverse Event Reporting System (VAERS) reporting form

[PDF - 49.30 KB]

Personal Author:

Suragh, Tiffany A. ; Miller, Elaine R. ; ...

Published Date:

March 25 2017

Source:

Vaccine. 35(18):2295-2297

Description:

Introduction:The Vaccine Adverse Event Reporting System (VAERS) is the spontaneous (passive) reporting system CDC and FDA use to monitor vaccine safet...

File Type:

[PDF - 49.30 KB]

File Type:

[PDF - 49.30 KB]
The complicated task of monitoring vaccine safety.

[PDF - 7.26 MB]

Personal Author:

Ellenberg, Susan S. ; Chen, Robert T. ;

Published Date:

1997 Jan-Feb

Source:

Public Health Rep. 112(1):10-21

Description:

Images

File Type:

[PDF - 7.26 MB]

File Type:

[PDF - 7.26 MB]
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)

[PDF - 580.38 KB]

Personal Author:

Shimabukuro, Tom T. ; Nguyen, Michael ; ...

Published Date:

Jul 22 2015

Source:

Vaccine. 33(36):4398-4405

Description:

The Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) conduct post-licensure vaccine safety monitoring ...

File Type:

[PDF - 580.38 KB]

File Type:

[PDF - 580.38 KB]

Enhancing vaccine safety capacity globally: a lifecycle perspective

Enhancing vaccine safety capacity globally: a lifecycle perspective

You May Also Like:

Have Questions?

CDC INFORMATION

CONNECT WITH CDC